Family Office Real Estate Daily · Family Office Real Estate Research Desk · Preview
Research Desk
A curated index of 20,216 CRE market research reports from the major institutional publishers — filterable by asset class, market and publisher. Editorial Family-Office interpretation layer is rolling out report-by-report.
Showing Family Office Briefings with a Co-GP / Platform angle — each card surfaces how a family office could deploy capital in that market.
317 reports
Page 10 / 14- SavillsMay 10, 2024
San Diego Q1 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a repeatable pipeline of deals.
- SavillsMay 10, 2024
Northern New Jersey Q1 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong deal pipeline.
- SavillsMay 10, 2024
New York Q1 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into New York's life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- SavillsMay 10, 2024
Denver-Boulder Q1 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level, focusing on established firms with a proven track record.
- SavillsMay 10, 2024
San Francisco Bay Area Q1 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- SavillsMay 10, 2024
Philadelphia Q1 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level to share in the promote and benefit from the growing capital invested.
- SavillsMay 10, 2024
The Life Sciences Tenant Q1 2024
Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor/operator focused on developing lab spaces to capitalize on the growing demand for flexible, pre-built environments.
- SavillsMay 10, 2024
Boston-Cambridge Q1 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a strong deal pipeline.
- SavillsMay 10, 2024
Washington D.C. Metro Region Q1 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into the Washington D.C. life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable investment pipeline.
- SavillsMay 10, 2024
Toronto Q1 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into Toronto's life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a strong pipeline of investment opportunities.
- CBREMay 8, 2024
San Diego Life Sciences Market Overview Q1 2024
Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- Cushman & WakefieldMay 3, 2024
Q1 2024 Raleigh Life Sciences Report
Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- CBREMay 3, 2024
Life Sciences Vacancy Rate Increases Amid Slowing Construction Pipeline, Modest Rise In Tenant Requirements
Life ScienceFamily Office Briefing →Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, focusing on those with a strong track record in navigating tenant requirements.
- ColliersMay 1, 2024
Life Sciences Report | 2024
Co-GP / Platform:A family office could deploy into the life sciences market by backing a specialized operator as a co-GP to leverage their expertise and share in the potential upside.
- CBREApr 24, 2024
Bay Area Life Sciences Figures Q1 2024
Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- TranswesternApr 19, 2024
US Life Sciences Market Research Report - Q4 2023
Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor with a proven track record in developing specialized facilities, sharing in the promote and benefiting from a strong pipeline of opportunities.
- CBREApr 19, 2024
Denver/Boulder Life Sciences Figures Q1 2024
Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.
- CBREApr 19, 2024
New York City Life Sciences Figures Q1 2024
Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- CBREApr 12, 2024
Philadelphia Life Sciences Figures Report Q1 2024
Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- NewmarkApr 12, 2024
Boston Life Sciences Market Report 1Q24
Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- CBREApr 10, 2024
Boston Metro Life Science Figures Q1 2024
Co-GP / Platform:A family office could deploy into the Boston life science market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- CBREMar 6, 2024
Philadelphia Life Sciences Figures Report Q4 2023
Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- ColliersFeb 28, 2024
Northern California Life Sciences Market Research Report H2 2023
Co-GP / Platform:A family office could deploy into the Northern California life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a strong deal flow.
- CBREFeb 28, 2024
New York City Life Sciences 2023 Year End Report
Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.
Research Hubs
Dedicated pages for every major publisher and market — each with aggregated KPI medians, asset-class breakdowns and the latest reports, read through a family-office lens.